Who We Empower
You are a Clinician
Objective data to diagnose, triage, and tailor care in one visit.
You are an Educator
Early, bias-free insight to personalise learning and protect equity.
You are a Family
Clear next steps—whether it’s enrichment for a child or support for an aging parent.
You are a Government or NGO
A science-backed talent and wellness lens to cut risk and drive performance.
Who We Serve
Five sectors, one seamless platform
Transforming Lives Together
ADHD
Autism
Dyslexia
Mild cognitive impairment
mTBI
Stroke rehabilitation
and more
The Global Problem
Brains are unique. Most systems pretend they're not.
Blind spots multiply
30 % of in-patients have undetected impairment
Time drains
Traditional neuro-psych tests take months, cost thousands.
Guesswork reigns
Discharge plans, IEPs, and promotions rely on intuition.
By 2050 more than 150 million people will face cognitive decline—without faster insight, outcomes and costs spiral.
Transforming Lives Together
18 patents & proprietary AI for unparalleled precision.
FDA-registered assessments plus adaptive digital therapy modules
Cloud-based, offline-ready—deploy in clinics, classrooms, or remote villages.
Multilingual interface (20+ languages) to eliminate cultural bias.
~95 % cheaper than traditional testing; results delivered instantly.
Two solution suites,
seamlessly integrated
OrangeCheck™
Rapid cognitive assessment & profiling
Purpose
Rapid, multidomain cognitive assessment & profiling
Who uses it?
Clinicians · Educators · HR / Safety leaders · Researchers
What it delivers
30-min tablet or web session
Instant report on attention, memory, executive function, processing speed & more
API / PDF export to EHR, LMS or HRIS
Session length
One-off or repeat every 2–12 weeks
Typical outcomes
<3 hrs clinician time per client
↑ 30–45 % decision accuracy
Baseline for discharge, IEP, hiring or wellness plans
Common next step
Trigger a ReadON™ programme to address flagged weaknesses
ReadON™
Evidence-based digital therapy to strengthen core skills
Purpose
Adaptive, game-based digital therapy that targets skill gaps
Who uses it?
Therapists · Teachers · Rehab teams · Families
What it delivers
15-20-min interactive exercises, 3–5 × week
Adaptive difficulty driven by proprietary AI
Real-time dashboards showing gains in reading fluency, working memory, processing speed
Session length
Ongoing; typical programmes run 6–12 weeks
Typical outcomes
↑ 1–2 grade-levels in reading after 8 weeks*
↓ 20–40 % attention-related errors in class or work*
↑ speed & accuracy on OrangeCheck™ retest
Common next step
Re-run OrangeCheck™ to prove the therapy gains
Proven Use-Cases
Psychiatry & Neurology
Discharge planning
Universal screenings
Talent acquisition
Impact Snapshot
Measurable improvements across key healthcare metrics
Assessment time
3 hours per case
Typical Gain with Orange
Cost per patient
↓ ~95%
Typical Gain with Orange
Readmission / dropout risk
↓ 20–40%
Typical Gain with Orange
Decision accuracy
↑ 30–45%
Typical Gain with Orange
Ready to replace guesswork with clarity?
Assess, understand, and elevate cognitive care — quickly, affordably, and at scale.
Start your free trial

Orange Neurosciences' Cognitive Skills Assessments (CSA) are intended as an aid for assessing the cognitive well-being of an individual. In a clinical setting, the CSA results (when interpreted by a qualified healthcare provider) may be used as an aid in determining whether further cognitive evaluation is needed. Orange Neurosciences' brain training programs are designed to promote and encourage overall cognitive health. Orange Neurosciences does not offer any medical diagnosis or treatment of any medical disease or condition. Orange Neurosciences products may also be used for research purposes for any range of cognition-related assessments. If used for research purposes, all use of the product must comply with the appropriate human subjects' procedures as they exist within the researcher's institution and will be the researcher's responsibility. All such human subject protections shall be under the provisions of all applicable sections of the Code of Federal Regulations.
© 2025 by Orange Neurosciences Corporation